FOXO4-dependent upregulation of superoxide dismutase-2 in response to oxidative stress is impaired in spinocerebellar ataxia type 3

Human Molecular Genetics

Volumn 20, Issue 15, 2011, Pages 2928-2941

  Araujo, Julieta ^a   Breuer, Peter ^a   Dieringer, Susanne ^a   Krauss, Sybille ^b   Dorn, Stephanie ^b   Zimmermann, Katrin ^a   Pfeifer, Alexander ^a   Klockgether, Thomas ^a   Wuellner, Ullrich ^a   Evert, Bernd O ^a  

^a UNIVERSITY OF BONN   (Germany)

^b GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATAXIN 3; MANGANESE SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXO4; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; CYTOTOXICITY; GENE EXPRESSION; GENE EXPRESSION REGULATION; HELA CELL; HUMAN; HUMAN CELL; NERVE CELL NECROSIS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN INTERACTION; PROTEIN TRANSPORT; RNA INTERFERENCE; SPINOCEREBELLAR ATAXIA TYPE 3; SPINOCEREBELLAR DEGENERATION; TRANSCRIPTION REGULATION; UBIQUITINATION;

BLOTTING, WESTERN; CELL SURVIVAL; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; HEK293 CELLS; HELA CELLS; HUMANS; HYDROGEN PEROXIDE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MACHADO-JOSEPH DISEASE; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; OXIDATIVE STRESS; PROTEIN BINDING; REACTIVE OXYGEN SPECIES; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTORS; UBIQUITINATION;

EID: 79960118539     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr197     Document Type: Article

References (52)

1. Orr, H.T. and Zoghbi, H.Y. (2007) Trinucleotide repeat disorders. Annu. Rev. Neurosci., 30, 575-621.
2. Shimohata, T., Nakajima, T., Yamada, M., Uchida, C., Onodera, O., Naruse, S., Kimura, T., Koide, R., Nozaki, K., Sano, Y. et al. (2000) Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription. Nat. Genet., 26, 29-36.
3. Takahashi, J., Tanaka, J., Arai, K., Funata, N., Hattori, T., Fukuda, T., Fujigasaki, H. and Uchihara, T. (2001) Recruitment of nonexpanded polyglutamine proteins to intranuclear aggregates in neuronal intranuclear hyaline inclusion disease. J. Neuropathol. Exp. Neurol., 60, 369-376.
4. McCampbell, A., Taylor, J.P., Taye, A.A., Robitschek, J., Li, M., Walcott, J., Merry, D., Chai, Y., Paulson, H., Sobue, G. et al.. (2000) CREB-binding protein sequestration by expanded polyglutamine. Hum. Mol. Genet., 9, 2197-2202.
5. Chai, Y., Shao, J., Miller, V.M., Williams, A. and Paulson, H.L. (2002) Live-cell imaging reveals divergent intracellular dynamics of polyglutamine disease proteins and supports a sequestration model of pathogenesis. Proc. Natl Acad. Sci. USA, 99, 9310-9315.
6. Wang, G., Sawai, N., Kotliarova, S., Kanazawa, I. and Nukina, N. (2000) Ataxin-3, the MJD1 gene product, interacts with the two human homologs of yeast DNA repair protein RAD23, HHR23A and HHR23B. Hum. Mol. Genet., 9, 1795-1803.
7. Burnett, B.G. and Pittman, R.N. (2005) The polyglutamine neurodegenerative protein ataxin 3 regulates aggresome formation. Proc. Natl Acad. Sci. SA, 102, 4330-4335.
8. Evert, B.O., Araujo, J., Vieira-Saecker, A.M., de Vos, R.A., Harendza, S., Klockgether, T. and Wüllner, U. (2006) Ataxin-3 represses transcription via chromatin binding, interaction with histone deacetylase 3, and histone deacetylation. J. Neurosci., 26, 11474-11486.
9. Evert, B.O., Vogt, I.R., Kindermann, C., Ozimek, L., de Vos, R.A., Brunt, E.R., Schmitt, I., Klockgether, T. and Wüllner, U. (2001) Inflammatory genes are upregulated in expanded ataxin-3-expressing cell lines and spinocerebellar ataxia type 3 brains. J. Neurosci., 21, 5389-5396.
10. Evert, B.O., Vogt, I.R., Vieira-Saecker, A.M., Ozimek, L., de Vos, R.A., Brunt, E.R., Klock-gether, T. and Wüllner, U. (2003) Gene expression profiling in ataxin-3 expressing cell lines reveals distinct effects of normal and mutant ataxin-3. J. Neuropathol. Exp. Neurol., 62, 1006-1018.
11. Chou, A.H., Yeh, T.H., Ouyang, P., Chen, Y.L., Chen, S.Y. and Wang, H.L. (2008) Poly-glutamine-expanded ataxin-3 causes cerebellar dysfunction of SCA3 transgenic mice by inducing transcriptional dysregulation. Neurobiol. Dis., 31, 89-101.
12. Li, F., Macfarlan, T., Pittman, R.N. and Chakravarti, D. (2002) Ataxin-3 is a histone-binding protein with two independent transcriptional corepressor ctivities. J. Biol. Chem., 277, 45004-45012.
13. Mueller, T., Breuer, P., Schmitt, I., Walter, J., Evert, B.O. and Wüllner, U. (2009) CK2-dependent phosphorylation determines cellular localization and stability of ataxin-3. Hum. Mol. Genet., 18, 3334-3343.
14. Reina, C.P., Zhong, X. and Pittman, R.N. (2010) Proteotoxic stress increases nuclear localization of ataxin-3. Hum. Mol. Genet., 19, 235-249.
15. Van der Heide, L.P., Hoekman, M.F. and Smidt, M.P. (2004) The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation. Biochem. J., 380, 297-309.
16. Van der Horst, A. and Burgering, B.M. (2007) Stressing the role of FoxO proteins in lifespan and disease. Nat. Rev. Mol. Cell Biol., 8, 440-450.
17. Evert, B.O., Wüllner, U., Schulz, J.B., Weller, M., Groscurth, P., Trottier, Y., Brice, A. and Klockgether, T. (1999) High level expression of expanded full-length ataxin-3 in vitro causes cell death and formation of intranuclear inclusions in neuronal cells. Hum. Mol. Genet., 8, 1169-1176.
18. Van der Horst, A., de Vries-Smits, A.M., Brenkman, A.B., van Triest, M.H., van den Broek, N., Colland, F., Maurice, M.M. and Burgering, B.M. (2006) FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP. Nat. Cell Biol., 8, 1064-1073.
19. Brenkman, A.B., de Keizer, P.L., van den Broek, N.J., Jochemsen, A.G. and Burgering, B.M. (2008) Mdm2 induces mono-ubiquitination of FOXO4. LoS ONE, 3, e2819.
20. Huang, H., Regan, K.M., Wang, F., Wang, D., Smith, D.I., van Deursen, J.M. and Tindall, D.J. (2005) Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation. Proc. Natl Acad. Sci. USA, 102, 1649-1654.
21. Matsuzaki, H., Daitoku, H., Hatta, M., Tanaka, K. and Fukamizu, A. (2003) Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation. Proc. Natl Acad. Sci. USA, 100, 11285-11290.
22. Burnett, B., Li, F. and Pittman, R.N. (2003) The polyglutamine neurodegenerative protein ataxin-3 binds polyubiquitylated proteins and has ubiquitin rotease activity. Hum. Mol. Genet., 12, 3195-3205.
23. Chai, Y., Berke, S.S., Cohen, R.E. and Paulson, H.L. (2004) Poly-ubiquitin binding by the polyglutamine disease protein ataxin-3 links its normal function to protein surveillance pathways. J. Biol. Chem., 279, 3605-3611.
24. Winborn, B.J., Travis, S.M., Todi, S.V., Scaglione, K.M., Xu, P., Williams, A.J., Cohen, R.E., Peng, J. and Paulson, H.L. (2008) The deubiquitinating enzyme ataxin-3, a polyglutamine disease protein, edits Lys63 linkages in mixed linkage ubiquitin chains. J. Biol. Chem., 283, 26436-26443.
25. Essers, M.A., Weijzen, S., de Vries-Smits, A.M., Saarloos, I., de Ruiter, N.D., Bos, J.L. and Burgering, B.M. (2004) FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. EMBO J., 23, 4802-4812.
26. Kops, G.J., Dansen, T.B., Polderman, P.E., Saarloos, I., Wirtz, K.W., Coffer, P.J., Huang, T.T., Bos, J.L., Medema, R.H. and Burgering, B.M. (2002) Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature, 419, 316-321.
27. Nemoto, S. and Finkel, T. (2002) Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway. Science, 295, 2450-2452.
28. Essers, M.A., de Vries-Smits, L.M., Barker, N., Polderman, P.E., Burgering, B.M. and Kors-wagen, H.C. (2005) Functional interaction between beta-catenin and FOXO in oxidative stress signaling. Science, 308, 1181-1184.
29. Silhan, J., Vacha, P., Strnadova, P., Vecer, J., Herman, P., Sulc, M., Teisinger, J., Obsilova, V. and Obsil, T. (2009) 14-3-3 protein masks the DNA binding interface of forkhead transcription factor FOXO4. J. Biol. Chem., 284, 19349-19360.
30. Xu, Y., Porntadavity, S. and St Clair, D.K. (2002) Transcriptional regulation of the human manganese superoxide dismutase gene: the role of specificity protein 1 (Sp1) and activating protein-2 (AP-2). Biochem. J., 362, 401-412.
31. Vogt, P.K., Jiang, H. and Aoki, M. (2005) Triple layer control: phosphorylation, acetylation and ubiquitination of FOXO proteins. Cell Cycle, 4, 908-13.
32. Lebovitz, R.M., Zhang, H., Vogel, H., Cartwright, J. Jr, Dionne, L., Lu, N., Huang, S. and Matzuk, M.M. (1996) Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc. Natl Acad. Sci. USA, 93, 9782-9787.
33. Williams, M.D., Van Remmen, H., Conrad, C.C., Huang, T.T., Epstein, C.J. and Richardson, A. (1998) Increased oxidative damage is correlated to altered mitochondrial function in heterozygous manganese superoxide dismutase knockout mice. J. Biol. Chem., 273, 28510-28515.
34. Van Remmen, H., Williams, M.D., Guo, Z., Estlack, L., Yang, H., Carlson, E.J., Epstein, C.J., Huang, T.T. and Richardson, A. (2001) Knockout mice heterozygous for Sod2 show alterations in cardiac mitochondrial function and apoptosis. Am. J. Physiol. Heart Circ. Physiol., 281, H1422-H1432.
35. Van Remmen, H., Ikeno, Y., Hamilton, M., Pahlavani, M., Wolf, N., Thorpe, S.R., Alderson, N.L., Baynes, J.W., Epstein, C.J., Huang, T.T. et al.. (2003) Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging. Physiol. enomics, 16, 29-37.
36. Strassburger, M., Bloch, W., Sulyok, S., Schüller, J., Keist, A.F., Schmidt, A., Wenk, J., Peters, T., Wlaschek, M., Lenart, J. et al. (2005) Heterozygous deficiency of manganese superoxide dismutase results in severe lipid peroxidation and spontaneous apoptosis in murine myocardium in vivo. Free adic. Biol. Med., 38, 1458-1470.
37. Sies, H. (1997) Oxidative stress: oxidants and antioxidants. Exp. Physiol., 82, 291-295.
38. Stack, E.C., Matson, W.R. and Ferrante, R.J. (2008) Evidence of oxidant damage in Hunting-ton's disease: translational strategies using antioxidants. nn. N. Y. Acad. Sci., 1147, 79-92.
39. Mojsilovic-Petrovic, J., Nedelsky, N., Boccitto, M., Mano, I., Georgiades, S.N., Zhou, W., Liu, Y., Neve, R.L., Taylor, J.P., Driscoll, M. et al. (2009) FOXO3a is broadly neuroprotective in vitro and in vivo against insults implicated in motor neuron diseases. J. Neurosci., 29, 8236-8247.
40. Freiman, R.N. and Tjian, R. (2002) Neurodegeneration. A glutamine-rich trail leads to transcription factors. Science, 296, 2149-2150.
41. Dunah, A.W., Jeong, H., Griffin, A., Kim, Y.M., Standaert, D.G., Hersch, S.M., Mouradian, M.M., Young, A.B., Tanese, N. and Krainc, D. (2002) Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease. Science, 296, 2238-2243.
42. Zhai, W., Jeong, H., Cui, L., Krainc, D. and Tjian, R. (2005) In vitro analysis of huntingtin-mediated transcriptional repression reveals multiple ranscription factor targets. Cell, 123, 1241-1253.
43. Schmitt, I., Linden, M., Khazneh, H., Evert, B.O., Breuer, P., Klockgether, T. and Wuellner, U. (2007) Inactivation of the mouse Atxn3 (ataxin-3) gene increases protein ubiquitination. Biochem. Biophys. Res. Commun., 362, 734-739.
44. Alves, S., Nascimento-Ferreira, I., Dufour, N., Hassig, R., Auregan, G., Nóbrega, C., Brouillet, E., Hantraye, P., Pedroso de Lima, M.C., Déglon, N. et al. (2010) Silencing ataxin-3 mitigates degeneration in a rat model of Machado-Joseph disease: no role for wild-type ataxin-3? Hum. Mol. Genet., 19, 2380-394.
45. Rodrigues, A.J., Coppola, G., Santos, C., Costa, Mdo, C., Ailion, M., Sequeiros, J., Geschwind, D.H. and Maciel, P. (2007) Functional genomics and biochemical characterization of the C. elegans orthologue of the Machado-Joseph disease protein ataxin-3. FASEB J., 21, 1126-1136.
46. Kuhlbrodt, K., Janiesch, P.C., Kevei, E., Segref, A., Barikbin, R. and Hoppe, T. (2011) The Machado-Joseph disease deubiquitylase ATX-3 couples ongevity and proteostasis. Nat. Cell Biol., 13, 273-281.
47. Hsu, A.L., Murphy, C.T. and Kenyon, C. (2003) Regulation of aging and age-related disease by DAF-16 and heat-shock factor. Science, 300, 1142-145.
48. Neitzel, H. (1986) A routine method for the establishment of permanent growing lympho-blastoid cell lines. Hum. Genet., 73, 320-326.
49. Haacke, A., Broadley, S.A., Boteva, R., Tzvetkov, N., Hartl, F.U. and Breuer, P. (2006) Proteolytic cleavage of polyglutamine-expanded ataxin-3 is critical for aggregation and sequestration of non-expanded ataxin-3. Hum. Mol. Genet., 15, 555-568.
50. Pfeifer, A. and Hofmann, A. (2009) Lentiviral transgenesis. Methods Mol. Biol., 530, 391-405.
51. Palmer, M.L., Lee, S.Y., Carlson, D., Fahrenkrug, S. and O'Grady, S.M. (2006) Stable knock-down of CFTR establishes a role for the channel in P2Y receptor-stimulated anion secretion. J. Cell Physiol., 206, 759-770.
52. Boeddrich, A., Gaumer, S., Haacke, A., Tzvetkov, N., Albrecht, M., Evert, B.O., Müller, E.C., Lurz, R., Breuer, P., Schugardt, N. et al.. (2006) An arginine/lysine-rich motif is crucial for VCP/p97-mediated modulation of ataxin-3 fibrillogenesis. EMBO J., 25, 1547-1558.